EGFR and cancer: A number of reported structures incorporating 1,2,3-triazole and sugar moieties as nucleoside analogues V-VII displayed potent cytotoxicity against different human cancer cell lines through their inhibitory efficiency upon EGFR, VEGFR-2 and/or CDK-2 kinases44–46 (Fig. 1).